跳至主要内容
临床试验/NCT04527770
NCT04527770已完成不适用

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients

Minia University1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
134
试验地点
1
主要终点
comparing efficacy of midazolam against dexmethasone in combination with bupivacaine 0.5%

研究概览

简要总结

midazolam and dexamethasone both can counteract chronic pain. either via GABA mimetic action or via anti prostaglandins

详细描述

Entrapement syndrome - namely median nerve compression in carpal tunnel syndrome - causes chronic pain that can be refractory to medical treatment . Ultrasound guided hydrodissection is an option for alleviating pain . Recurrence is the main side effect of injection. We try in this research to prevent recurrence rate . Midazolam and dexamethasone both are used in chronic pain . Midazolm act by GABA mimetic action while dexamethasone act by decrease interleukin formation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

both drugs are the same colour and volume injected by a staff member not aware of study design

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • numbness or pain in the nerve distribution, nerve conduction studies (NCS) corresponding with AANEM guidelines
  • Nerve cross sectional area >12mm2

排除标准

  • Refusal to participate
  • History of operation in median nerve.were patient refusal to participate, pain recurrence after previous injection and severe symptoms requiring surgical release, diabetic patients

研究组 & 干预措施

dexamethasone group

Active Comparator

sonar guided median nerve hydrodissection by bupivacaine 0.5% and dexamethasone

干预措施: Dexamethasone (Drug)

midazolam group

Active Comparator

sonar guided median nerve hydrodissection by bupivacaine 0.5% and midazolam

干预措施: Midazolam injection (Drug)

结局指标

主要结局

comparing efficacy of midazolam against dexmethasone in combination with bupivacaine 0.5%

时间窗: up to 6 months

use of visual analogue score

次要结局

  • Subjective pain assesment(up to 6 months)
  • complications(pain recurrence after 6 months, neurotoxicity immediately after injection)
  • Nerve electrophysiology(up to 6 months)
  • nerve sonogram(up to 6 months)

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Maher

Principle investigator

Minia University

研究点 (1)

Loading locations...

相似试验

Midazolam Versus Dexamethasone as an Adjuvant to... | 临床试验